chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), in Oct2021 06:30 PM as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 64 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "lymphoma" (unspecified if ongoing), notes: Other medical history: lymphoma/follicular/DLBCL/HEP B carrier; "follicular" (unspecified if ongoing), notes: Other medical history: lymphoma/follicular/DLBCL/HEP B carrier; "DLBCL" (unspecified if ongoing), notes: Other medical history: lymphoma/follicular/DLBCL/HEP B carrier; "HEP B carrier" (unspecified if ongoing), notes: Other medical history: lymphoma/follicular/DLBCL/HEP B carrier; "Known allergies: Cat scan iodine" (unspecified if ongoing), notes: Known allergies: Cat scan iodine. Concomitant medication(s) included: VEMLIDY, start date: Jan2020, stop date: May2022. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (22May2022) negative; (25May2022) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.   Clinical course: The patient received Other medication in 2 weeks.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
PEDV AX HIB administered after temperature excursion.; This spontaneous report was received from a physician (also reported as an other) referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.        On 26-FEB-2021, the patient was administered haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength and route were not provided; lot# was T026959 and expiration date was 11-MAR-2023) 0.5 ml involved in a temperature excursion for prophylaxis (product storage error).   The administered dose experienced a temperature excursion at 19.7 degree Celsius for 1 hour. There was no previous temperature excursion. The temperature excursion was detected by a data logger.
This spontaneous report was received from a nurse prescriber and refers to a 8-year-old male patient. There was no information about the patient's concurrent conditions and medical history provided. On 15-AUG-2018, the patient was vaccinated with one dose of improperly stored VAQTA 25/0.5 (units not provided), lot # R002086, expiration date: 22-APR-2019 (site and route of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion between 47 degrees Fahrenheit and 77 degrees Fahrenheit for 1o minutes. Digital Data Logger was involved. There was previous excursions reported. Sender's Comments: US-009507513-1808USA009736.
8 weeks after receiving my second dose of the Pfizer vaccine I lost a significant amount of hearing in the right ear.
Sharp pain within 48 hours of injection. Pain subsided, but after 1 week patient started to notice more muscle pain during overhead movement or reaching behind. Pain getting worse until this day.
PATIENT CLAIMS STILL BLEEDING FROM THE INJECTION SITE, INFORMED PATIENT TO REACH OUT TO THEIR DOCTOR AND EXPLAINED THE LOCATION OF THE BLEEDING WAS NOT WHERE HE WAS VACCINATED, IT COULD BE DUE TO SOME OTHER FACTORS.
...1 day after Covid and flu vaccines?Passed out again today. Symptoms were exactly as prior episode. (Blurry vision , extreme sweating, altered state of consciousness followed by bowel movement, nausea) Fully recovered after 15 minutes . Did not proceed to ER since there appears to be a causal relationship between vaccination and passing out. Regarding my nutrition / fluid status I had just drank tea and ate breakfast.  So weird! This is the second occurrence after vaccine #4 also
Per mom by 5:30pm he c/o his throat feeling funny but no reap sx. Then a few minutes later his hands were bright red and then his chest. She gave him a dose of BENADRYL and Alb. inhaler he got worse then started gasping for air. Went to ER and when arrived his hands, arms, legs and lips were purple.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Weakness-Mild, Additional Details: pt partner notified me after shot pt fainted.  called 911. applied cool compress and offered sip water to wake pt. 911 arrived recommend pt take to ed.
LEFT SHOULDER WAS SWOLLEN. COULD NOT LIFT ARM. INTENSE PAIN AT NIGHT THIS STARTED DAY AFTER VACCINE. WENT TO DR WHERE HE ASPIRATED MY SHOULDER SENT FLUID OUT TO LAB TO RULE OUT INFECTION. WAS DETERMINED TO BE INFLAMMATION.
Vaccine produced anti body that gave me Idiopathic Thrombocytopenia Purpura which reduced blood platelets level to a low of 4.4k platelets.  I was hospitalized for four days and given blood platelet transfusion, then three treatments of IV immunoglobins, prednisone then weekly Rituxin treatments.  Platelets started to increase after about four weeks to 140k after that and back to normal in about 8 weeks.  Prednisone was stopped after about 45 days.  Bone marrow biopsey was done while in a local hospital which showed marrow was producing good platelets but anti body caused by the vaccine was destroying the platelets at a greater rate.  This can be verified by Dr. and the hospital .
Staff were unaware that patient had already received his first Moderna Booster dose at the previous facility on 2/18/22. Patient inadvertently administered the second Moderna Booster dose only 3 months after receiving their first booster dose.
VACCINE EXPOSURE VIA BREAST MILK; This spontaneous report received from a parent concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient's parent received covid-19 vaccine ad26.cov2.s (suspension for injection, Transmammary, batch number: Unk) dose was not reported, administered on 16-MAR-2021 for an unspecified indication. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced vaccine exposure via breast milk. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine exposure via breast milk was not reported. This report was non-serious.
Patient received 0.3ml of COVID19 pfizer vaccine as Booster. Patient was watched in the clinic for 15 minutes after receiving dose and discharged without any noted adverse reaction or complaints. Pfizer vaccine vial was NOT diluted with 1.8ml of  0.9% Sodium Chloride prior to administration of dose. Error was discovered only after patient had left clinic. Supervisor notified. Remainder of vial was discarded. Patient was called, patient stated that she felt good and had no symptoms of fever, headache, arm pain, body aches, or shortness of breath. Advised patient to continue to watch for any adverse reaction of the vaccine, such as persistent fever, shortness of breath, severe headache, or chest pain, and to go immediately to the nearest emergency department if these symptoms present.
Shoulder pain immediately. 6 AM muscle aches over entire body. Unable to function normally for 24 hous. Weakness, shivery. I did have the vaccine several years prior to getting this new vaccine with no adverse effects - only to contract the shingles virus last September 2017 of which the pain of the left side of my body lasted for all of eight to 10 months. I therefore wanted protection from ever getting the shingles again and was happy to hear of the latest vaccine of which I had no problems with the 1st part of the series.
pt recv vax 23MAY96 & in 1996 pt exp a local rxn @ inj site & arm swelling;pt exp was serious enough to keep the pt home from school;
This spontaneous report was received from a physician via an unspecified reporter referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 01-FEB-2016, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 PK 0.5mL SD-PFS-LLokwTip 10PK" and lot number L014876 with expiration date of 13-JAN-2017 (route of administration and anatomical location were not reported), which was stored at a lowest recorded temperature of 27F (-2.777777778 Celsius) for 1764 hours. The vaccine status was reported as excursion and the storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Tingling in arm inject about 1 hour post vaccine. Symptom now is tendon/joint pain in thumb and pointer finger of arm injected.
Large (about 1") area with nodule on right arm/deltoid which is red and painful to touch and in raising arm. A small module (about 1/2" d) at 2 weeks after injection at the same site. No pain.
Kidney pain on left side only, frequent urination,  finger tips constantly tingling and gets very bad when using phone or a surface mouse on a laptop. Prescribed pain relievers.
Pt devel fever 103, red-warm-swollen @ inject site, ice & then warm pack & APAP given;
5/25/11 at 0500 - temp: 103 F. Febrile seizure. Evaluated at ER. No cough, no rhinorrhea since D/C from ER, playful without seizure activity. Pt eating well, no cough, no rhinorrhea last fever 5/26/2011 temp: 100.5 F.
MUCOSAL ULCERS ON VAGINA; CANKER SORES ON LABIA; MUCOSAL ULCER ON LABIA; FEVERISH; JOINT PAIN; ON AND OFF HEADACHE; FEELING BAD; This spontaneous report received from a parent concerned a 20 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included headache, and other pre-existing medical conditions included the patient was not pregnant at the time of vaccination. The patient was previously treated with acetylsalicylic acid/caffeine/paracetamol for on and off headache.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced feeling bad. On APR-2021, the subject experienced on and off headache. On 04-APR-2021, the subject experienced joint pain. On 05-APR-2021, the subject experienced mucosal ulcers on vagina. On 05-APR-2021, the subject experienced canker sores on labia. On 05-APR-2021, the subject experienced mucosal ulcer on labia. On 05-APR-2021, the subject experienced feverish. On 07-APR-2021, treatment medications included: benzocaine. Additional treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from joint pain, feeling bad, on and off headache, and feverish on APR-2021, and had not recovered from mucosal ulcers on vagina, canker sores on labia, and mucosal ulcer on labia. This report was non-serious.; Sender's Comments: V0-  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
In the weeks after 2nd vaccine dose, experienced chest tightness/pain in heart area. At the time I thought this was due to recent weight gain and lack of good sleep, however now I believe it is related to the heart inflammation symptoms reported in the media by outlets such as Reuters. The tightness/pain was intermittent meaning it did not occur all the time, but I would feel it for some part of the day and it would recur. This lasted for about a month and seems to have gotten better. However, I am about to schedule an appointment with a cardiologist in order to get this looked at as I am worried of what other unknown side effects will be in time.
(R) arm erythema, swelling warmth - Prescribed BENADRYL, and amoxicillin 250 mg one q 8 hours x 10 days.
Admit to Medical Center 7/9/2021. Intubated 7/18-7/24 & 7/26-7/30
Itching tingling all over my body Icy hot feeling or sunburn type feeling all over- pins and Needles type feelings hands arms legs ears forehead head and then hives broke out behind my ear and one on my forehead
He had the 2nd Pfizer covid vaccine on Thursday late afternoon. By Friday evening, he was complaining of chest pain and shortness of breath. He was also running a fever. Called the advice line for his dr and were told to monitor him. Saturday early morning, took him to urgent care due to no improvement. They did an x-ray and other tests to rule out myocarditis. His symptoms eventually resolved on Monday.
cannot lift the arm; unbearable pain in shoulder; unbearable pain to elbow; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (cannot lift the arm), ARTHRALGIA (unbearable pain in shoulder) and ARTHRALGIA (unbearable pain to elbow) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 26-Jan-2021. Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included SEMAGLUTIDE (OZEMPIC) and INSULIN GLARGINE (LANTUS) for Diabetes mellitus, FLUOXETINE HYDROCHLORIDE (PROZAC) and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION COMPLICATION (cannot lift the arm), ARTHRALGIA (unbearable pain in shoulder) and ARTHRALGIA (unbearable pain to elbow). At the time of the report, VACCINATION COMPLICATION (cannot lift the arm), ARTHRALGIA (unbearable pain in shoulder) and ARTHRALGIA (unbearable pain to elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Caller received her initial dose of Moderna vaccine yesterday, February 26. Unbearable pain on her LEFT shoulder to elbow and she cannot lift her shoulder
Nausea; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration on 23Jan2021 at a single dose for COVID-19 immunization. Medical history included ongoing acid reflux, ongoing Meniere's disease, and unspecified health issues. Concomitant medication included rivaroxaban (XARELTO). On 25Jan2021, a couple of days later from vaccination, the patient had nausea. She wanted to know if the nauseous feeling had to do with the vaccine or the acid reflux or the Meniere's. The patient asked whether she should get the second shot if she is not feeling well on 13Feb2021, which is when she is supposed to get the second shot. Outcome of the event was unknown.  Information about batch/lot number has been requested.
Felt some dripping/discharge/leaking from injection site/backtracking; A spontaneous report, concerning a 26 year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and felt some dripping after the administrator removed the needle (Vaccination site leakage).  The patient's medical history was not provided. No concomitant medications were reported.  On 14 Feb2021, prior to the onset of the events, the patient received a dose of mRNA-1273 (Lot number: 011M20A), intramuscularly for prophylaxis of COVID-19 infection. The patient reported feeling some dripping after the removal of the vaccination needle. No treatment information was provided. The dose number the patient received was unknown.    On 14 Feb 2021, the patient reported that she felt some dripping after the administrator removed the needle.  No treatment information was provided.  Action taken with second dose of mRNA-1273 in response to the events was unknown/not reported.  The event, felt some dripping, was considered as resolved on 14 Feb 2021.; Reporter's Comments: This report refers to a case of discharge/leaking from vaccination injection site for mRNA-1273, lot # 001M20A with no associated AEs.
Diarrhea, vomiting started evening of 3/28/07 & 3/30/07. Patient went to doctor on 3/29/07. No further vomiting. Diarrhea is less. Patient has red throat and placed on Amoxicilin.
Diarrhoea; Breathing difficult; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-May-2021 and was forwarded to Moderna on 05-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), DYSPNOEA (Breathing difficult) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporte.  Concomitant products included DUPILUMAB (DUPIXENT) for an unknown indication.    On 22-Mar-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced DIARRHOEA (Diarrhoea), DYSPNOEA (Breathing difficult) and HEADACHE (Headache). At the time of the report, DIARRHOEA (Diarrhoea), DYSPNOEA (Breathing difficult) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       on 22 march patient was prescribed to took two week treatment of steroids and same was finished on 2nd april.
This spontaneous report was received from a certified nurse practitioner concerning a patient of unknown gender and age who on an unknown date was vaccinated with the third dose of GARDASIL only 8 weeks after the second dose was given (route, lot number and expiration date were not provided). No adverse effects were reported. Additional information has been requested
I received the 1st dose of the Moderna COVID vaccine on 2/11 at 1pm.  I experienced only mild soreness at injection site for a couple of days after receiving the vaccine  Then on 2/23 (day 12) a red blotch appeared on my upper arm around injection site.  It was irregular in shape, approx. 2 inches across, and smooth with redness appearing below the skin.  Skin felt warm to touch but did not itch.  Red blotch grew in size on 2/24 (day 13) to approx. 2.5 inches across.  On 2/25 the blotch was the same size but not as red.  On 2/26 the blotch was barely noticeable.  I did not take any action to alleviate the reaction because it did not itch or bother me.
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 08/01/2021. PATIENT FULLY VACCINATED ON 02/18/2021.
Flu-like symptoms for close to 24 hours.  Body aches, weak, tired, headaches, hot/cold flashes.
On the evening I received my shot I ran fever, my body ached terribly my from my neck down and BOTH  epitrochlear nodes located  on the inside of my elbows were swollen (large - like small round balls). The right side was larger than the left one. They are still swollen today. I have not seen a doctor.
Patient tested positive for Covid 19 on 7/23/2021 after symptom onset of 7/21/2021. Highest temperature recorded was 101. Symptoms included fever, chills, runny nose, sore throat, cough, shortness of breath, headache, loss of taste and smell, fatigue, confusion and increased heart rate. Symptomatic from 7/21 through at least 7/26 when disease investigation was completed.
8/22/2021:  presented to ER with chest pain, troponin elevation and abnormal EKG, taken to coronary angiography urgently showing angiographically normal coronary arteries.  Echocardiogram next morning shows LVEF 50-55% with apical wall motion abnormality.  9/8/2021:  presented to ER again with acute chest pain, troponin elevation, and abnormal EKG.  Patient left against medical advice after hospitalist evaluation and recommendation for admission.  Repeat echocardiogram is now pending as outpatient.
No adverse event; A patient was administered a dose of the Moderna COVID-19 vaccine monovalent as a booster; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (A patient was administered a dose of the Moderna COVID-19 vaccine monovalent as a booster) and NO ADVERSE EVENT (No adverse event) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Nov-2022, the patient experienced WRONG PRODUCT ADMINISTERED (A patient was administered a dose of the Moderna COVID-19 vaccine monovalent as a booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (A patient was administered a dose of the Moderna COVID-19 vaccine monovalent as a booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (A patient was administered a dose of the Moderna COVID-19 vaccine monovalent as a booster).    No concomitant information provided No treatment information provided
pt pt wakened in am & felt ver warm;mom did not take T;to ER; pt given advil & observed for 4 hrs'sent home;no further probs
This spontaneous report was received from the health worker refers to an unspecified number of patients of unknown age and gender. On an unspecified day, VAQTA underwent an excursion and the excursion was supported. On an unspecified dates, unspecified number of patients were administered with post excursion supported VAQTA (Strength, dose, route and lot number were not reported) for an unknown indication. No adverse effects had been reported by any patients. This is one of the several reports from the same reporter. Additional information has been requested.
upper left leg muscle hurting since first dose. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (upper left leg muscle hurting since first dose) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (upper left leg muscle hurting since first dose). At the time of the report, MYALGIA (upper left leg muscle hurting since first dose) outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Hives to clothing contact areas and at both injection site. Was given HIB and Prevnar at the site right thigh.
Acute hypoxic respiratory failure from COVID-19 viral pneumonitis + COVID 19 test
It was reported that a female pt received a TD vaccine on 4/9/99 and reportedly, 2 days later, the pt experienced "swelling, redness and warmth to touch at the site of injection". The pt reportedly, went to the doctor. From additional information received on 5/17/99, it was reported that the pt recovered from this experience.